[
    {
        "@id": "http://purl.org/np/RAhdb2ky18c7iWCym5q6GrKQLe3E-jLPt_NamaGIXPsQ4#pubinfo",
        "@graph": [
            {
                "@id": "http://purl.org/np/RAhdb2ky18c7iWCym5q6GrKQLe3E-jLPt_NamaGIXPsQ4#sig",
                "http://purl.org/nanopub/x/hasAlgorithm": [
                    {
                        "@value": "RSA"
                    }
                ],
                "http://purl.org/nanopub/x/hasPublicKey": [
                    {
                        "@value": "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"
                    }
                ],
                "http://purl.org/nanopub/x/hasSignature": [
                    {
                        "@value": "IrVnfsuN9YBtm6HDj0SB7+Qb4LfYTtnl9DrIoTM+qmOAGlYa5g8QFnnndFinsL10inhf4crD2JPvdy5jGFFK8vOEGotI8H1f6/x+fjiQTs/6usyh8nuCWiFcQcXpZn6Xs5J5Oj8EYcPKu7vmxEd+Bvwnr2xb6VbaZzM8pvZPqeo="
                    }
                ],
                "http://purl.org/nanopub/x/hasSignatureTarget": [
                    {
                        "@id": "http://purl.org/np/RAhdb2ky18c7iWCym5q6GrKQLe3E-jLPt_NamaGIXPsQ4"
                    }
                ]
            },
            {
                "@id": "http://purl.org/np/RAhdb2ky18c7iWCym5q6GrKQLe3E-jLPt_NamaGIXPsQ4",
                "http://purl.org/dc/terms/created": [
                    {
                        "@value": "2021-07-03T13:02:43.973+02:00",
                        "@type": "http://www.w3.org/2001/XMLSchema#dateTime"
                    }
                ],
                "http://purl.org/dc/terms/creator": [
                    {
                        "@id": "https://orcid.org/0000-0002-1468-3557"
                    }
                ],
                "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate": [
                    {
                        "@id": "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM"
                    }
                ],
                "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate": [
                    {
                        "@id": "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM"
                    }
                ],
                "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate": [
                    {
                        "@id": "http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs"
                    }
                ]
            }
        ]
    },
    {
        "@id": "http://purl.org/np/RAhdb2ky18c7iWCym5q6GrKQLe3E-jLPt_NamaGIXPsQ4#Head",
        "@graph": [
            {
                "@id": "http://purl.org/np/RAhdb2ky18c7iWCym5q6GrKQLe3E-jLPt_NamaGIXPsQ4",
                "http://www.nanopub.org/nschema#hasAssertion": [
                    {
                        "@id": "http://purl.org/np/RAhdb2ky18c7iWCym5q6GrKQLe3E-jLPt_NamaGIXPsQ4#assertion"
                    }
                ],
                "http://www.nanopub.org/nschema#hasProvenance": [
                    {
                        "@id": "http://purl.org/np/RAhdb2ky18c7iWCym5q6GrKQLe3E-jLPt_NamaGIXPsQ4#provenance"
                    }
                ],
                "http://www.nanopub.org/nschema#hasPublicationInfo": [
                    {
                        "@id": "http://purl.org/np/RAhdb2ky18c7iWCym5q6GrKQLe3E-jLPt_NamaGIXPsQ4#pubinfo"
                    }
                ],
                "@type": [
                    "http://www.nanopub.org/nschema#Nanopublication"
                ]
            }
        ]
    },
    {
        "@id": "http://purl.org/np/RAhdb2ky18c7iWCym5q6GrKQLe3E-jLPt_NamaGIXPsQ4#assertion",
        "@graph": [
            {
                "@id": "http://purl.obolibrary.org/obo/DOID_2998",
                "https://w3id.org/biolink/vocab/category": [
                    {
                        "@id": "https://w3id.org/biolink/vocab/Disease"
                    }
                ]
            },
            {
                "@id": "http://purl.org/np/RAhdb2ky18c7iWCym5q6GrKQLe3E-jLPt_NamaGIXPsQ4#association",
                "http://www.w3.org/1999/02/22-rdf-syntax-ns#object": [
                    {
                        "@id": "http://purl.obolibrary.org/obo/DOID_2998"
                    }
                ],
                "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate": [
                    {
                        "@id": "https://w3id.org/biolink/vocab/treats"
                    }
                ],
                "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject": [
                    {
                        "@id": "https://identifiers.org/drugbank:DB00970"
                    }
                ],
                "@type": [
                    "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement"
                ],
                "http://www.w3.org/2000/01/rdf-schema#label": [
                    {
                        "@value": "dactinomycin for injection is an actinomycin indicated for the treatment of 1 1 1 2 1 3 1 4 1 5 1 6 dactinomycin for injection is indicated for the treatment of adult and pediatric patients with wilms tumor as part of a multi phase combination chemotherapy regimen dactinomycin for injection is indicated for the treatment of adult and pediatric patients with rhabdomyosarcoma as part of a multi phase combination chemotherapy regimen dactinomycin for injection is indicated for the treatment of adult and pediatric patients with ewing sarcoma as part of a multi phase combination chemotherapy regimen dactinomycin for injection is indicated for the treatment of adult and pediatric patients with metastatic nonseminomatous testicular cancer as part of a multi phase combination chemotherapy regimen dactinomycin for injection is indicated for the treatment of post menarchal patients with gestational trophoblastic neoplasia as a single agent or as part of a combination chemotherapy regimen dactinomycin for injection is indicated for the treatment of adult patients with locally recurrent or locoregional solid malignancies as a component of palliative or adjunctive regional perfusion"
                    }
                ],
                "https://w3id.org/biolink/vocab/association_type": [
                    {
                        "@id": "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation"
                    }
                ],
                "https://w3id.org/biolink/vocab/provided_by": [
                    {
                        "@id": "https://w3id.org/um/NeuroDKG"
                    }
                ],
                "https://w3id.org/biolink/vocab/relation": [
                    {
                        "@id": "https://schema.org/TreatmentIndication"
                    }
                ]
            },
            {
                "@id": "https://identifiers.org/drugbank:DB00970",
                "https://w3id.org/biolink/vocab/category": [
                    {
                        "@id": "https://w3id.org/biolink/vocab/Drug"
                    }
                ]
            }
        ]
    },
    {
        "@id": "http://purl.org/np/RAhdb2ky18c7iWCym5q6GrKQLe3E-jLPt_NamaGIXPsQ4#provenance",
        "@graph": [
            {
                "@id": "http://purl.org/np/RAhdb2ky18c7iWCym5q6GrKQLe3E-jLPt_NamaGIXPsQ4#assertion",
                "http://www.w3.org/ns/prov#wasAttributedTo": [
                    {
                        "@id": "https://orcid.org/0000-0002-1468-3557"
                    }
                ]
            }
        ]
    }
]